Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atara Biotherap (NQ: ATRA )

14.37 USD +0.03 (+0.21%)
Streaming Delayed Price Updated: 10:02 AM EDT, Oct 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,857
Open 14.43
Bid (Size) 14.30 (2)
Ask (Size) 14.44 (3)
Prev. Close 14.34
Today's Range 14.25 - 14.49
52wk Range 4.520 - 19.36
Shares Outstanding 43,949,486
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Atara Biotherapeutics To Present Clinical Data in Epstein-Barr Virus-Driven (EBV+) Acquired & Primary Immunodeficiency Lymphoproliferative Diseases (AID-LPD and PID-LPD) from Tab-Cel® Expanded Access
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases... 
From Business Wire News Releases
Atara Biotherapeutics Announces All Progressive Multiple Sclerosis Patients with Sustained Disability Improvement at Six Months Confirmed Improvement at 12 Months in the Phase 1a Study of ATA188
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments for patients with severe diseases, including... 
From Business Wire News Releases

Performance

YTD
-12.43%
-12.43%
1 Month
+11.05%
+11.05%
3 Month
+3.38%
+3.38%
6 Month
+60.20%
+60.20%
1 Year
+16.83%
+16.83%

More News

Read More
Interesting ATRA Put And Call Options For June 2021
Tags Stocks
From Market News Video
Atara Biotherapeutics Announces FDA Clearance of IND for ATA2271, a Next-Generation Autologous Mesothelin-Targeted CAR T with Novel PD1DNR and 1XX Technologies Combined to Treat Solid Tumors
From Business Wire News Releases
Interesting ATRA Put And Call Options For November 20th
Tags Stocks
From Market News Video
Atara Biotherapeutics to Present 12-Month Data from All Four Cohorts in the Phase 1a Study of ATA188 in Progressive Multiple Sclerosis at MSVirtual2020
From Business Wire News Releases
Stocks With Rising Relative Strength: Atara Biotherapeutics
From Investor's Business Daily
Atara Biotherapeutics Announces Second Quarter 2020 Financial Results and Operational Progress
From Business Wire News Releases
Thinking about buying stock in CleanSpark, Atara Biotherapeutics, FuelCell Energy, Sorrento Therapeutics, or Plug Power?
From PR Newswire
Atara Biotherapeutics to Announce Second Quarter 2020 Financial Results on Wednesday, August 5, 2020
From Business Wire News Releases
Stocks Showing Market Leadership: Atara Biotherapeutics Earns 92 RS Rating
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.